Latest Health News

Tag: high-dose

  • J&J arthritis drug goes up against Humira, with mixed results

    —

    by

    admin
    in

    (Reuters) – Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial. By one measure, patients with moderate to severe disease who took sirukumab showed significantly greater improvement in the Phase III study than those taking Humira, J&J said on Saturday. In…